Table 1 Disparities in clinicopathological features among patients with LNM- and LNM+

Age (Mean ± SD, years)

53.72 ± 10.00

55.13 ± 9.99

-1.191

0.235

Age (n, %)

1.303

0.521

 ≤ 45

42 (23.0%)

21(18.1%)

 45–60

91(49.7%)

58 (50.0%)

 >60

50(27.3%)

37 (31.9%)

Histologic type (n, %)

2.608

0.271

 Invasive ductal

169 (92.3%)

111(95.7%)

 Invasive lobular

4(2.2%)

3 (2.6%)

 Others

10(5.5%)

2 (1.7%)

ER (n, %)

0.176

0.675

 Negative

40 (21.9%)

23(19.8%)

 Positive

143(78.1%)

93 (80.2%)

PR (n, %)

0.663

0.416

 Negative

52 (28.4%)

28(24.1%)

 Positive

131 (71.6%)

88 (75.9%)

HER2 (n, %)

3.678

0.055

 Negative

147 (80.3%)

82(70.7%)

 Positive

36 (19.7%)

34 (29.3%)

Ki-67 (n, %)

3.026

0.082

 < 20%

93 (50.8%)

47(40.5%)

 ≥ 20%

90(49.2%)

69 (59.5%)

P53 (n, %)

1.591

0.207

 Negative

52 (28.4%)

41(35.3%)

 Positive

131 (71.6%)

75 (64.7%)

Molecular type (n, %)

7.083

0.069

 luminal A

69 (37.7%)

41(35.3%)

 luminal B

75(41.0%)

53 (45.7%)

 HER2

15 (8.2%)

16(13.8%)

 TNBC

24(13.1%)

6 (5.2%)

LVI (n, %)

12.067

0.001

 Absent

152(83.1%)

76(65.5%)

 Present

31(16.9%)

40 (34.5%)